LeukoStrat® CDx FLT3 Mutation Assay
The only CE-IVD marked assay for selection of acute myeloid leukemia (AML) patients eligible for treatment with midostaurin or gilteritinib fumarate.
LymphoTrack® Dx Assay kits are designed for the identification of gene rearrangements in hematologic samples utilizing NGS technologies
Invivoscribe’s LymphoTrack® Dx Assays are used to identify and track clonal lymphocyte populations. These CE-IVD assays, developed for use with the leading Next-Generation Sequencing (NGS) platforms, include optimized multiplex PCR master mixes with primers incorporating platform specific adapters and specimen tracking sequencing identification tags for a one-step PCR workflow. A comprehensive bioinformatics software package is provided free of charge with purchase; enabling you to identify the DNA sequence, clonal prevalence, V-J family identity for each gene rearrangements, and with the IGH assays, the extent of IGHV somatic hypermutation (SHM). With this state-of-the-art assay, the gene rearrangement status of several million lymphocytes in blood, bone marrow, or tissue samples can be both identified and characterized.
The LymphoTrack Dx MiSeq master mixes are designed with 24 TruSeq indices and adapters for the Illumina MiSeq instrument, allowing one-step PCR, pooling of amplicons, and loading onto the flowcell.
The LymphoTrack Dx PGM master mixes are designed with 12 Ion Xpress™ indices and adapters for the Ion PGM instrument, allowing one-step PCR, pooling of amplicons, and loading onto the chip.
We gladly support you by keeping you updated on our latest products and the developments around our services.